These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
    Author: Albertazzi A, Bonadio M, Fusaroli M, Lotti T, Miano L, Salvia G, Sasdelli M, Villa G, Zucchelli P, Ventriglia L.
    Journal: Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293.
    Abstract:
    A multicenter comparative study was carried out to evaluate the efficacy of aztreonam and gentamicin in 186 patients with symptomatic renal or urinary tract infections. Patients were divided randomly into two groups: 94 patients received aztreonam 1 g/day intramuscularly and 92 patients received gentamicin 80 mg i.m. twice daily. The clinical and microbiologic results found a single daily dose of aztreonam to be more effective than gentamicin b.i.d. Furthermore, no evidence of side effects was seen with aztreonam. Such results are generally thought to ensure better compliance in outpatients.
    [Abstract] [Full Text] [Related] [New Search]